---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-23-000044"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:09:00.104232+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Moderna CCO cancels 10b5-1 trading plan; no trades executed

## Summary
- Arpa Garay, Chief Commercial Officer, adopted a 10b5-1 plan on August 24, 2023.
- Plan cancelled on November 6, 2023, following disclosure of Q3 2023 results.
- Sales under the plan were to begin no earlier than November 27; no shares sold or options exercised.

## SEC filing metadata
- accession: 0001682852-23-000044
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285223000044/0001682852-23-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285223000044/mrna-20231106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-23-000044
- JSON: https://secwatch.observer/filing/0001682852-23-000044.json
- Plain text: https://secwatch.observer/filing/0001682852-23-000044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.